🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📢 NEW RESEARCH📢 iKnife can reliably diagnose endometrial cancer and help thousands of healthy women get all-clear quicker Research from ⁦⁦Imperial NHS 💙⁩ led by the brilliant team ⁦Sadaf Ghaem-Maghami 💙⁩ supported by Eve theguardian.com/society/2023/j…

Our experts have discovered that the iKnife can accurately detect endometrial cancer. Led by Sadaf Ghaem-Maghami, our Professor of Gynaecological Oncology, this research could help thousands of women get the all-clear quicker. Sadaf Ghaem-Maghami 💙 Read more ⬇️ ow.ly/uAT550MiqAz

- whole system based, not individual hospital based so limiting selection bias. UK experience in deriving and auditing as per these QPI maybe useful for other public funded systems. Fotopoulou/Cunnea Ovarian Cancer Research group Stephen Dobbs Nick Wood Sadaf Ghaem-Maghami 💙 GO Girls

Coming up on RN Breakfast: 08.15 - Sadaf Ghaem-Maghami 💙 on detection of endometrial cancer 08.23 - olivia ansell, Artistic Director of Sydney Festival 08.45 - Catherine Henry of Catherine Henry Lawyers on what happens when somebody dies without a will LISTEN LIVE: abc.net.au/listenlive/rad…

Cancer de l’endomètre : un bistouri capable de détecter des cellules malignes en temps réel – via Le Monde lemonde.fr/sciences/artic…

Delighted to see our paper on impact of 3 COVID waves on gynae oncology services out in Cancers. mdpi.com/2072-6694/15/4… Multiple waves of the COVID-19 pandemic led to significant disruption of gynaecological cancer services in the UK.

It’s GET LIPPY DAY 💋 The Eve Appeal is asking us to reflect on what they wish they’d known sooner about gynae & reproductive health Here’s to all the brilliant doctors, clinicians & nurses who make it much easier for people to advocate for themselves #GetLippy #youngerselfie

A new research project, led by S&C's Sadaf Ghaem-Maghami 💙, has been awarded funding from Target Ovarian Cancer Cancer and will explore immunotherapy for high grade serous #OvarianCancer. Find out more ⬇️ targetovariancancer.org.uk/news/exploring…

Over the moon that Target Ovarian Cancer has awarded funding to this groundbreaking research led by the brilliant Professor Sadaf Ghaem-Maghami 💙 with Dr Haonan Lu Imperial College London Huge thanks to our brilliant Target Ovarian Cancer supporters for making this funding possible 👏👏🏿👏🏽 #ovariancancer

➡️Do you treat women with ovarian cancer?👇 Imperial Clinical Analytics Research & Evaluation are seeking diverse healthcare professionals to complete a short survey on retrieving information from electronic health records✍️ Interested? 🗓️Complete the survey by 31/07/23 forms.microsoft.com/e/1NzErMS549

Fascinating visit today to our Target Ovarian Cancer funded research project at Imperial College London led by the brilliant Sadaf Ghaem-Maghami 💙 This is highly innovative research exploring the use of immunotherapy in #ovariancancer Find out more here ⬇️ targetovariancancer.org.uk/exploring-immu…

Stanford Top 2% of scientists for 2023 Christina Fotopoulou Fotopoulou/Cunnea Ovarian Cancer Research group Charles Coombes Andrea Rockhall Andrea Rockall Iain McNeish OCA Research Centre James Flanagan James Flanagan Eric Aboagye Simak Ali Simak Ali Sadaf Ghaem-Maghami Sadaf Ghaem-Maghami 💙 tinyurl.com/3hycf67b

Zoltan Takats, Burak Temelkuran, Sadaf Ghaem-Maghami and Josephine Bunch received a Programme Award jointly funded with Engineering and Physical Sciences Research Council to improve surgical precision with real-time in-situ cancer biology information. [1/2] ZTakatsLab@Imperial | Sadaf Ghaem-Maghami 💙 | Imperial College London | #CRUKFunded

September is #GynaecologicalCancerAwarenessMonth. To mark it, we're launching our agenda for the new UK government: Three targets to transform the future of #ovariancancer. And we need your help! 📣 Email your MP 👉 bit.ly/3R7azB2 (1/2)

Self citation

sciencedirect.com/science/articl… Great to see our paper from UKCTOCS in EBioMedicine today. The window period for detection of ovary cancer early stage disease (pre clinical detectable phase) is only ~12months. The invivo tumour doubling time is ~2.9 months.

A UK-first! 📢 After over 25 years of research, a woman has given birth to a baby girl following a womb transplant. Meet baby Amy and her mum Grace: imperial.nhs.uk/about-us/news/…